What is the best course of action for a pregnant patient at 35 weeks of gestation with severe fetal growth restriction and absent end-diastolic flow on umbilical artery Doppler?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Delivery by Caesarean Section

At 35 weeks gestation with severe fetal growth restriction (fundal height corresponding to 29 weeks) and absent end-diastolic flow (AEDV) on umbilical artery Doppler, you should proceed with immediate delivery by caesarean section (Option B). This patient has already exceeded the recommended delivery window of 33-34 weeks for AEDV, making further delay inappropriate 1.

Rationale for Immediate Delivery

  • The Society for Maternal-Fetal Medicine explicitly recommends delivery at 33-34 weeks of gestation for pregnancies with fetal growth restriction and absent end-diastolic velocity, and this patient is already at 35 weeks, meaning delivery should not be delayed 1, 2.

  • AEDV represents severe placental insufficiency with obliteration of approximately 70% of placental tertiary villi arteries, creating high risk for intrauterine fetal demise and adverse developmental outcomes 2.

  • The neonatal morbidity and mortality rates associated with AEDV at this gestational age are lower than the risks of continued intrauterine exposure to severe placental insufficiency 3.

Why Caesarean Section Over Induction

  • For pregnancies with fetal growth restriction complicated by AEDV, cesarean delivery should be strongly considered based on the complete clinical scenario, as recommended by the Society for Maternal-Fetal Medicine 1, 2.

  • Growth-restricted fetuses with AEDV demonstrate intrapartum fetal heart rate decelerations requiring emergency cesarean delivery in 75-95% of cases, making planned cesarean delivery the safer approach 3.

  • These fetuses are at markedly increased risk for metabolic acidemia and emergency situations during labor, which can be avoided with planned cesarean delivery 3.

Why Not the Other Options

Option A (Induce labor) is inappropriate because:

  • The fetus is already severely compromised with AEDV, indicating inability to tolerate the stress of labor 3.
  • The high likelihood (75-95%) of requiring emergency cesarean delivery during labor makes planned cesarean delivery safer 3.

Option C (Repeat Doppler in 1 week) is contraindicated because:

  • The patient has already passed the recommended delivery window of 33-34 weeks 1.
  • When AEDV is detected, Doppler assessment should be performed 2-3 times per week to monitor for deterioration to reversed end-diastolic velocity, not to delay delivery beyond the recommended gestational age 1.
  • Further delay increases the risk of intrauterine fetal demise without providing fetal benefit 2, 4.

Pre-Delivery Preparations

  • Coordinate with neonatology for optimal resuscitation planning, as these infants are at risk for respiratory distress syndrome, necrotizing enterocolitis, and intraventricular hemorrhage 2.

  • While antenatal corticosteroids are recommended if delivery is anticipated before 33 6/7 weeks or between 34 0/7 and 36 6/7 weeks, at 35 weeks the benefit is limited but should be considered if not previously administered 1, 2.

  • Magnesium sulfate for neuroprotection is not indicated at 35 weeks, as this is reserved for pregnancies <32 weeks gestation 1.

Common Pitfalls to Avoid

  • Do not attempt expectant management beyond the recommended delivery window hoping for additional fetal maturation—the risks of continued placental insufficiency outweigh any potential benefits 4, 5.

  • Do not rely on biophysical profile or cardiotocography alone to determine delivery timing when AEDV is present, as these may appear reassuring even when the fetus is severely compromised 3.

  • Do not delay delivery to reach 37 weeks—the recommendation for delivery at 33-34 weeks with AEDV is based on evidence that neonatal outcomes at this gestational age are superior to the risks of continued intrauterine exposure 1, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fetal Growth Restriction and Absent End-Diastolic Flow Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Timing of Delivery for Fetal Growth Restriction (FGR) with Abnormal Dopplers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The clinical significance of absent or reverse end-diastolic flow in the fetal aorta and umbilical artery.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 1991

Related Questions

What is the best course of action for a pregnant woman at 35 weeks of gestation with significant fetal growth restriction and absent end-diastolic flow on umbilical artery Doppler (ultrasound)?
What is the best course of action for a primigravida (first-time pregnant woman) at 37 weeks gestation with severe hypertension, fetal growth restriction, and absent end diastolic flow?
What is the best course of action for a fetus with reversed end-diastolic flow on umbilical artery Doppler?
What is the most appropriate management for a patient at 33 weeks' gestation with a small for gestational age (SGA) fetus and reversed end-diastolic flow on umbilical artery Doppler?
What is the best course of action for a 30-something year old primigravida (first-time pregnant woman) at 37 weeks gestational age (GA) with severe hypertension, irritated on examination, and absent end diastolic flow?
What is the difference between Lyrica (pregabalin) and gabapentin in terms of treatment and dosage?
What is the best course of treatment for an elderly patient with a UTI due to Klebsiella pneumoniae, acute delirium, and multiple comorbidities, including chronic respiratory failure, anemia, and traumatic skin tears?
What is the recommended dose of alpha lipoic acid (ALA) for non-diabetic neuropathy?
What are the indications for chest tube thoracostomy (CTT) insertion in patients with empyema?
What is the recommended dosage of Bactrim (trimethoprim/sulfamethoxazole) for pediatric patients with a urinary tract infection (UTI)?
Against which of the following bacterial genera is ampicillin (Ampicilina) not active: Pseudomonas?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.